Inventor · disambiguated record
Rosalynn Molden
Also filed as: MOLDEN ROSALYNN
3 granted patents·3 pending applications·2 citations·filing 2021–2023
52Inventor score
Files withREGENERON PHARMA6
Top patents by PatentIndex Score
6 records- 0191US11787867B2Anti-GITR antibodies and uses thereofREGENERON PHARMA·Filed 2021·Granted Oct 17, 2023·2 cites·24 claims
- 0277US12331127B2Therapeutic uses of anti-GITR antibodiesREGENERON PHARMA·Filed 2023·Granted Jun 17, 2025·0 cites·55 claims
- 0360US2023279046A1Size exclusion chromatography for characterizing host cell proteinsREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0460US2023408527A1Methods for characterizing host-cell proteinsREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0556US2023166199A1Methods for characterizing host-cell proteinsREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 0655US12169199B2Activity based host cell protein profilingREGENERON PHARMA·Filed 2021·Granted Dec 17, 2024·0 cites·29 claims
Join the waitlist — get patent alerts
Get an alert when Rosalynn Molden files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →